Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-068772

Chief Operating Officer gave up 1,784 shares (to pay taxes)

  • Chief Operating Officer acquired 3,516 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
BILINSKY IGOR Chief Operating Officer 2024-06-03 Option exercise +3,516 41,542 D
BILINSKY IGOR Chief Operating Officer 2024-06-03 Shares withheld for taxes −1,784 $8.37 $14,932 39,758 D
Derivatives
BILINSKY IGOR Chief Operating Officer 2024-06-03 Option exercise · Restricted Stock Units −3,516 24,613 D
Loading xslF345X05/tm2416581-2_4seq1.xml…